LifeMD Q2 revenue up 23% to $62.2M, adjusted EBITDA up 223% to $7.1M; revises FY2025 guidance

LifeMD, Inc.

2025-Q3 EPS reported -$0.08 revenue$127,915,941

Total revenue $62.2M (+23% YoY), telehealth revenue $48.6M (+30%); telehealth adjusted EBITDA $3.4M (+560%).
Adjusted EBITDA $7.1M (+223% YoY); generated >$8M operating cash flow.
Paid down $2.1M senior debt, ended quarter with $36.2M cash; fully repaid all senior debt post-quarter.
Launched nationwide behavioral health offering, acquired virtual women's health brand, upgraded LifeMD+ membership.
Revised FY2025 guidance downward due to temporary challenges at Rex MD, still expects strong YoY growth.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.